Tag: TV46000mdcIRM
MedinCell SA: Teva and MedinCell received full response letter for TV-46000/mdc-IRM
PARSIPPANY, NJ, TEL AVIV & PARIS – Teva Pharmaceuticals, American subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and MedinCell (Euronext: MEDCL) today announce that the U.S. Food…
Teva and MedinCell have received a complete response letter for TV-46000/mdc-IRM – 04/19/2022 at 23:15
PARSIPPANY, NJ, TEL AVIV & PARIS – Teva Pharmaceuticals, US subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and MedinCell (Euronext: MEDCL) today announce that the U.S. Food…